Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on Clinical Outcomes
Authors:
Open Access
- 1 November 2019
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 65 (11) , 1363-1374
Abstract
BACKGROUND: For medical tests that have a central role in clinical decision-making, current guidelines advocate outcome-based analytical performance specifications. Given that empirical (clinical trial-style) analyses are often impractical or unfeasible in this context, the ability to set such specifications is expected to rely on indirect studies to calculate the impact of test measurement uncertainty on downstream clinical, operational, and economic outcomes. Currently, however, a lack of awareness and guidance concerning available alternative indirect methods is limiting the production of outcome-based specifications. Therefore, our aim was to review available indirect methods and present an analytical framework to inform future outcome-based performance goals.CONTENT: A methodology review consisting of database searches and extensive citation tracking was conducted to identify studies using indirect methods to incorporate or evaluate the impact of test measurement uncertainty on downstream outcomes (including clinical accuracy, clinical utility, and/or costs). Eighty-two studies were identified, most of which evaluated the impact of imprecision and/or bias on clinical accuracy. A common analytical framework underpinning the various methods was identified, consisting of 3 key steps: (a) calculation of “true” test values; (b) calculation of measured test values (incorporating uncertainty); and (c) calculation of the impact of discrepancies between (a) and (b) on specified outcomes. A summary of the methods adopted is provided, and key considerations are discussed.CONCLUSIONS: Various approaches are available for conducting indirect assessments to inform outcome-based performance specifications. This study provides an overview of methods and key considerations to inform future studies and research in this area.Keywords
Funding Information
- National Institute for Health Research
- Cancer Research UK (C8640/A23385)
- Innovate UK
This publication has 91 references indexed in Scilit:
- Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniquesBMC Nephrology, 2012
- Systematic Bias in Genomic Classification Due to Contaminating Non-neoplastic Tissue in Breast Tumor SamplesBMC Medical Genomics, 2011
- Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic ModelsMedical Decision Making, 2011
- Decision-Analytic Modeling to Evaluate Benefits and Harms of Medical Tests: Uses and LimitationsMedical Decision Making, 2009
- Lax sphygmomanometer standard causes overdetection and underdetection of hypertension: a computer simulation studyBlood Pressure Monitoring, 2008
- The impact of bias in MoM values on patient risk and screening performance for Down syndromePrenatal Diagnosis, 2007
- Lack of sphygmomanometer calibration causes over- and under-detection of hypertension: a computer simulation studyJournal Of Hypertension, 2006
- The extent and implications of sphygmomanometer calibration error in primary careJournal of Human Hypertension, 2001
- 6.1.2.3 Prenatal Screening for Neural Tube Defects, Quality Specification for Maternal Serum Alphafetoprotein AnalysisUpsala Journal of Medical Sciences, 1993
- Optimal screening for patients with hyperparathyroidism with use of serum calcium observations. A decision-theoretical analysisScandinavian Journal of Clinical and Laboratory Investigation, 1983